Source: Beximco Pharmaceuticals Ltd. (BXPHARMA) | FY 2014-15 | Page 5

# Statement of Cash Flows

**Reporting Period:** For the Year ended 31 December 2015  
**Reporting Currency & Multiplier:** BDT (Amount in Taka) | **Scale Multiplier:** 1.0

### Cash Flows From Operating Activities

| Particulars | 2015 | 2014 |
| --- | --- | --- |
| Receipts from Customers and Others | 12,820,931,378 | 11,085,037,894 |
| Payments to Suppliers and Employees | (10,115,051,359) | (8,240,584,352) |
| Cash Generated from Operations | 2,705,880,019 | 2,844,453,542 |
| Interest Paid | (708,970,234) | (724,314,963) |
| Interest Received | 304,321,405 | 489,970,647 |
| Income Tax Paid | (466,112,250) | (394,128,824) |
| Net Cash Generated from Operating Activities | 1,835,118,940 | 2,215,980,402 |

### Cash Flows From Investing Activities

| Particulars | 2015 | 2014 |
| --- | --- | --- |
| Acquisition of Property, Plant and Equipment | (2,520,276,389) | (2,778,797,453) |
| Intangible Assets | (49,069,233) | (56,321,506) |
| Disposal of Property, Plant and Equipment | 3,918,658 | 7,615,792 |
| Dividend Received | 1,427,955 | 1,427,955 |
| Decrease in Short Term Investment | 935,596,823 | 551,356,330 |
| Net Cash Used in Investing Activities | (1,628,402,186) | (2,274,718,882) |

### Cash Flows From Financing Activities

| Particulars | 2015 | 2014 |
| --- | --- | --- |
| Net Increase/(Decrease) in Long Term Borrowings | 75,983,828 | (340,756,861) |
| Net Increase in Short Term Borrowings | 10,430,182 | 376,855,168 |
| Dividend Paid | (367,893,892) | (350,853,554) |
| Net Cash Generated from Financing Activities | (281,479,882) | (314,755,247) |

### Summary of Cash Flows and Per Share

| Particulars | 2015 | 2014 |
| --- | --- | --- |
| Decrease in Cash and Cash Equivalents | (74,763,128) | (373,493,727) |
| Cash and Cash Equivalents at Beginning of Year | 222,239,239 | 595,732,966 |
| Cash and Cash Equivalents at End of Year | 147,476,111 | 222,239,239 |
| Net Operating Cash Flow Per Share | 4.75 | 6.02 |
| Number of Shares used to compute Net Operating Cash Flow Per Share | 386,244,234 | 367,851,652 |